| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/18/2013 | CN102670510B Tripterine nanostructure lipid carrier modified by lentiviral vector and appliance for preparing and treating prostatic cancer, lung cancer and breast cancer drug |
| 09/18/2013 | CN102670494B Eye drop and preparation method and application thereof |
| 09/18/2013 | CN102670493B Lomefloxacin hydrochloride eye drops and preparation method and application thereof |
| 09/18/2013 | CN102631336B Freeze-drying orally disintegrating tablet with vitamin K1 composition for infants and preparation method for freeze-drying orally disintegrating tablet |
| 09/18/2013 | CN102631319B Phellinus linteus polysaccharide oral liposome medicine and preparation technology thereof |
| 09/18/2013 | CN102614143B High-stability vitamin C tablet and preparing process thereof |
| 09/18/2013 | CN102579352B Clarithromycin freeze-dried liposome and preparation method thereof |
| 09/18/2013 | CN102552393B Spica Prunellae injection for animals and preparation method thereof |
| 09/18/2013 | CN102526746B Preparation method of enteric type aqueous dispersion coating material |
| 09/18/2013 | CN102526406B Traditional Chinese medicine plaster for treating cervical spondylotic radiculopathy and preparation method thereof |
| 09/18/2013 | CN102525911B Methyhaaltrexone bromide injection and preparation method thereof |
| 09/18/2013 | CN102492078B Acrylic acid and polyhedral silsesquioxane copolymerized hydrogel, its preparation method and its purpose |
| 09/18/2013 | CN102488749B Preparation method of nux vomica powder preparation |
| 09/18/2013 | CN102481287B Pharmaceutical composition of temozolomide comprising vitamin c or vitamin c derivative and preparation method thereof |
| 09/18/2013 | CN102440978B Copper sodium chlorophyllate tablets and preparation method thereof |
| 09/18/2013 | CN102370611B Temperature-sensitive hydrogel containing exendin-4 and injection thereof |
| 09/18/2013 | CN102319217B Polysaccharide coated magnetic nano-particle and preparation method |
| 09/18/2013 | CN102295926B Fluorescent mesoporous silicon oxide nanomaterial and preparation method and application thereof |
| 09/18/2013 | CN102293743B Lipid microsphere composition |
| 09/18/2013 | CN102225047B Enteric solid oral dosage form of bisphosphonate containing a chelating agent |
| 09/18/2013 | CN102204889B Degarelix acetate lyophilized powder injection and preparation method thereof |
| 09/18/2013 | CN102188636B Bamboo shoot extract with function of improving anemia, preparation method thereof and compound preparation thereof |
| 09/18/2013 | CN102101037B Preparation method of alginate/epsilon-polylysine/alginate biological microcapsule |
| 09/18/2013 | CN102099020B Stabilized transdermal drug delivery system |
| 09/18/2013 | CN102091055B Calcium dobesilate capsule and preparation method thereof |
| 09/18/2013 | CN102018672B Freeze-dried liposome composition of water-soluble medicament and preparation method thereof |
| 09/18/2013 | CN101941077B Method for preparing magnetic metal iron-encapsulated fullerene carbon spheres |
| 09/18/2013 | CN101926798B Dispersible tablet containing amlodipine and valsartan |
| 09/18/2013 | CN101824091B G-CSF (Granulocyte-Colony Stimulating Factor) fusion protein mutant, preparation method and application thereof |
| 09/18/2013 | CN101822673B Iloperidone-containing solid medicinal composition |
| 09/18/2013 | CN101269212B Gargle capable of being swallowed |
| 09/18/2013 | CN101237851B Estrogen compositions for vaginal administration |
| 09/18/2013 | CN101155592B Method for the mitigation of symptoms of contact lens related dry eye |
| 09/17/2013 | US8536380 Triterpene-containing oleogel-forming agent, triterpene-containing oleogel and method for producing a triterpene-containing oleogel |
| 09/17/2013 | US8536231 Methods for treating diabetic foot ulcers |
| 09/17/2013 | US8536230 Methods for regulating gelation of polysaccharide solutions and uses thereof |
| 09/17/2013 | US8536228 Transdermal compositions |
| 09/17/2013 | US8535879 Structuring hydrogels |
| 09/17/2013 | US8535799 Controlled agglomeration |
| 09/17/2013 | US8535728 Colloidal silver composition having antimicrobial properties |
| 09/17/2013 | US8535721 Pharmaceutical microspheres containing valproic acid for oral administration |
| 09/17/2013 | US8535712 Radiation sensitive liposomes |
| 09/17/2013 | US8535707 Devices and methods for delivering active agents to the osteomeatal complex |
| 09/17/2013 | US8535705 In situ crosslinking of biocompatible condensation polymers from small nontoxic precursors; vascular grafts, controlled release drug delivery, medical device coatings, wound dressings and surgical sealants |
| 09/17/2013 | US8535692 Local anesthetic emulsion compositions and methods of making and using the same |
| 09/17/2013 | US8535678 Anti-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 09/17/2013 | US8535673 A humanized antibody that specifically binds an epitope contained within positions 13-28 of A beta; used for treating Alzheimer's disease in both asymptomatic patients and those currently showing symptoms of disease. |
| 09/17/2013 | US8535660 Nutritional supplements for pregnant women |
| 09/17/2013 | US8535659 Nutritional supplements for pregnant women |
| 09/17/2013 | US8535656 Amphiphilic polymer-protein conjugates and methods of use thereof |
| 09/17/2013 | US8535650 Stabilized reverse micelle compositions and uses thereof |
| 09/17/2013 | US8535646 Method of inhibiting harmful microorganisms and barrier-forming composition therefor |
| 09/17/2013 | CA2810477C Oral drug delivery system |
| 09/17/2013 | CA2690773C Pharmaceutical liquid composition of botulinum toxin with improved stability |
| 09/17/2013 | CA2685349C Temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution |
| 09/17/2013 | CA2673646C Formation of medically useful gels comprising microporous particles and methods of use |
| 09/17/2013 | CA2606583C Aldehyde conjugated flavonoid preparations |
| 09/17/2013 | CA2555666C Therapeutic and diagnostic conjugates for use with multispecific antibodies |
| 09/17/2013 | CA2532394C Rg1 antibodies and uses thereof |
| 09/17/2013 | CA2470377C Solid dosage form for the ocular administration of an active principle, a soluble, solid ophthalmic insert and the production method thereof |
| 09/12/2013 | WO2013134636A1 Compositions and methods for delivery of kinase inhibiting peptides |
| 09/12/2013 | WO2013134349A1 Delivery systems for enhancing drug efficacy |
| 09/12/2013 | WO2013134177A1 Methods and compositions for improving spinal surgery outcomes |
| 09/12/2013 | WO2013134129A2 Derivatized polyglucosamines for delivery of small molecules, peptides, and proteins |
| 09/12/2013 | WO2013133927A1 Pharmaceutical compositions of 2'-c-methyl-guanosine, 5'-[2-[(3-hydroxy-2,2-dimethyl-1-oxopropyl)thio]ethyl n-(phenylmethyl)phosphoramidate] |
| 09/12/2013 | WO2013133702A1 Methods and compositions for stabilizing dried biological materials |
| 09/12/2013 | WO2013133659A1 An improved process for preparation of physiologically active polypeptide complex |
| 09/12/2013 | WO2013133543A1 Calcium carrier, and chelated calcium pha granule and microorganism comprising same |
| 09/12/2013 | WO2013133419A1 Novel sugar-derived gelling agent |
| 09/12/2013 | WO2013133413A1 Mucosa-elevating agent |
| 09/12/2013 | WO2013133408A1 Liquid medicine for internal use |
| 09/12/2013 | WO2013133405A1 Pharmaceutical composition containing peptide |
| 09/12/2013 | WO2013133388A1 Adhesive patch |
| 09/12/2013 | WO2013133387A1 Adhesive patch |
| 09/12/2013 | WO2013133297A1 Method for stimulating t cell and use thereof |
| 09/12/2013 | WO2013133221A1 micro-RNA INHIBITOR |
| 09/12/2013 | WO2013132670A1 Semi-solidified nutritive agent |
| 09/12/2013 | WO2013132485A1 Polymers having therapeutically active agents conjugated thereto, processes of preparing same and uses thereof |
| 09/12/2013 | WO2013132268A1 Chemical modification of antibodies |
| 09/12/2013 | WO2013132252A1 Diagnostic marker compounds and their use |
| 09/12/2013 | WO2013132169A1 Novel silicone acrylate and acrylic acid thickening polymer reducing the stickiness of glycerine-based cosmetic formulas |
| 09/12/2013 | WO2013132054A1 Prevention of infection |
| 09/12/2013 | WO2013132044A1 Combination therapy of antibodies against human csf-1r and uses thereof |
| 09/12/2013 | WO2013131988A1 Composition for care and hygiene of the ear canal |
| 09/12/2013 | WO2013131987A1 Anti-p-selectin antibody formulation |
| 09/12/2013 | WO2013131986A1 Production of pharmaceutical protective coatings with good resistance in a neutral environment |
| 09/12/2013 | WO2013131866A1 Abeta antibody formulation |
| 09/12/2013 | WO2013131215A1 Polymer micro-needle array chip, preparation process and use thereof |
| 09/12/2013 | WO2013106766A3 THERAPEUTIC INDICATIONS OF miR-1291 |
| 09/12/2013 | WO2013103301A3 Method for preparing cell targeting conjugates, and the complexes obtained |
| 09/12/2013 | WO2013102842A3 Device and composition for drug release |
| 09/12/2013 | WO2013092673A3 New combination |
| 09/12/2013 | WO2012100366A8 Liposome and personal care composition comprising thereof |
| 09/12/2013 | US20130237687 Vitamin-targeted imaging agents |
| 09/12/2013 | US20130237614 Bioresorable polymer matrices and methods of making and using the same |
| 09/12/2013 | US20130237613 Sugar-based surfactant microemulsions containing essential oils for cosmetic and pharmaceutical use |
| 09/12/2013 | US20130237611 Aqueous formulations of (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4-trifluorobutane-1-sulfonate |
| 09/12/2013 | US20130237608 Prolonged Release Pharmaceutical Composition Containing 3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)Phenol |
| 09/12/2013 | US20130237589 Aptamer therapeutics useful in the treatment of complement-related disorders |
| 09/12/2013 | US20130237565 Pharmaceutical compositions of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide |